These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7882187)

  • 1. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
    Jia X; Brown JC; Kwok YN; Pederson RA; McIntosh CH
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
    Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
    Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat.
    Eissele R; Koop H; Arnold R
    Scand J Gastroenterol; 1990 May; 25(5):449-54. PubMed ID: 1972810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach.
    Lippl F; Kircher F; Erdmann J; Allescher HD; Schusdziarra V
    Regul Pept; 2004 Jun; 119(1-2):93-8. PubMed ID: 15093702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat gastric somatostatin and gastrin release: interactions of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide.
    Eissele R; Bothe-Sandfort E; Göke B; Eng J; Arnold R; Koop H
    Life Sci; 1994; 55(8):629-34. PubMed ID: 7913983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of glucagon-like peptide-1(7-36) amide and gastric inhibitory polypeptide or cholecystokinin on insulin and glucagon secretion from the isolated perfused rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Metabolism; 1992 Apr; 41(4):359-63. PubMed ID: 1556941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
    Oben J; Morgan L; Fletcher J; Marks V
    J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
    Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
    Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
    Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
    Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.
    Ding WG; Renström E; Rorsman P; Buschard K; Gromada J
    Diabetes; 1997 May; 46(5):792-800. PubMed ID: 9133546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of glucagon-like peptide-1-(7-36) amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum.
    Dumoulin V; Dakka T; Plaisancie P; Chayvialle JA; Cuber JC
    Endocrinology; 1995 Nov; 136(11):5182-8. PubMed ID: 7588257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man.
    Wettergren A; Petersen H; Orskov C; Christiansen J; Sheikh SP; Holst JJ
    Scand J Gastroenterol; 1994 Jun; 29(6):501-5. PubMed ID: 7915853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
    Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
    FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
    Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
    Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets.
    Siegel EG; Schulze A; Schmidt WE; Creutzfeldt W
    Eur J Clin Invest; 1992 Mar; 22(3):154-7. PubMed ID: 1582439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCK-1 and CCK-2 receptor agonism do not stimulate GLP-1 and neurotensin secretion in the isolated perfused rat small intestine or GLP-1 and PYY secretion in the rat colon.
    Modvig IM; Christiansen CB; Rehfeld JF; Holst JJ; Veedfald S
    Physiol Rep; 2020 Jan; 8(2):e14352. PubMed ID: 31984675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.